JOURNAL SCAN: GENERAL TOPICS: Recent Articles of Interest to Practitioners

Generali, Joyce
March 2006
Hospital Pharmacy;Mar2006, Vol. 41 Issue 3, p299
Academic Journal
Presents a list of articles on topics related to hospital pharmacy as of March 2006. "Brand Confusion Causes Allergic Dermatitis"; "Using the Internet to Provide Information Prescriptions"; " Potential for Alcohol and Prescription Drug Interactions in Older People"; "Can Statin Therapy Reduce the Risk of Breast Cancer?"


Related Articles

  • An understanding of the pharmacokinetics of HMG-CoA reductase inhibitors should help reduce the incidence of serious drug interactions.  // Drugs & Therapy Perspectives;Dec2003, Vol. 19 Issue 12, p21 

    Discusses the role of the pharmokinetics of HMG-CoA reductase inhibitors or statins in helping reduce the incidence of serious drug interactions. Function of the inhibitors in cholesterol synthesis; Information on adverse events associated with statins, including skeletal muscle abnormalities;...

  • ARE STATINS really safe? Phelps, Kerryn // Australian Women's Weekly;Mar2014, Vol. 84 Issue 3, p154 

    The article explores the negative side-effects of using statins to reduce the risk of heart attacks and strokes. Topics discussed include statins being among the most used popular classes of drugs in Australia, the negative impact of using statins as a preventive measure or a way of making up...

  • Risk for statin toxicity with concomitant macrolide antibiotic.  // Reactions Weekly;6/22/2013, Issue 1458, p4 

    The article reports on a study which investigated the adverse events and the risk of statin toxicity among patients who were coprescribed clarithromycin or erythromycin.

  • Sorafenib.  // Reactions Weekly;Sep2014, Vol. 1520 Issue 1, p196 

    The article presents a case study of a 53-year old male patient who developed dermatitis during treatment with sorafenib for liver cirrhosis.

  • Prevalence of Potentially Severe Drug-Drug Interactions in Ambulatory Patients with Dyslipidaemia Receiving HMG-CoA Reductase Inhibitor Therapy. Bravo, Alexandra E. Rätz; Tchambaz, Lydia; Krähenbühl-Melcher, Anita; Hess, Lorenzo; Schlienger, Raymond G.; Krähenbühl, Stephan // Drug Safety;2005, Vol. 28 Issue 3, p263 

    Background: Drug-drug interactions (DDIs) are a well known risk factor for adverse drug reactions. HMG-CoA reductase inhibitors (‘statins’) are a cornerstone in the treatment of dyslipidaemia and patients with dyslipidaemia are concomitantly treated with a variety of additional...

  • Use statins cautiously.  // Prevention India;Jul2013, p2 

    The article focuses on the risk associated with the use of statins. It is noted that a 20% higher risk of joint aches, muscular pains, sprains and dislocations are possessed by statin users. It is noted that reductions in cholesterol are achieved by statins but exercise is recommended for...

  • Rhabdomyolysis in a patient receiving atorvastatin and fluconazole. Kahri, Juhani; Valkonen, Miia; Bäcklund, Tom; Vuoristo, Matti; Kivistö, Kari // European Journal of Clinical Pharmacology;Feb2005, Vol. 60 Issue 12, p905 

    Presents a case study of rhabdomyolysis after concomitant use of fluconazole and simvastatin. Increase of the potential for myotoxicity; Description of rhabdomyolysis as a rare adverse event of statin therapy; Management of statin-related myopathy; Awareness of the harmful drug interactions of...

  • Statins Plus Niacin: Safe? Crawford, Michael H. // Clinical Cardiology Alert;Apr2007, Vol. 26 Issue 4, p29 

    THE FOOD AND DRUG ADMINISTRATION (FDA) cautions about increased risks of adverse events with the combination of statins and niacin, yet achieving current lipid treatment targets often requires multiple drug therapy. Thus, these investigators reviewed adverse events reported to the FDA over 5...

  • Safety Aspects of Statins: Which Factors Create the Adverse Effects of Statins. Makino, Hisashi; Harada-Shiba, Mariko // Immunology, Endocrine & Metabolic Agents - Medicinal Chemistry;Jun2008, Vol. 8 Issue 2, p172 

    Statins have been shown to have beneficial effects on myocardial infarction, revascularization, stroke, and cardiovascular mortality in numerous clinical trials. Seven kinds of statins are available today and have different characteristics in their efficacy of LDL-lowering, their metabolism and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics